Curtis E Margo

Summary

Country: USA

Publications

  1. ncbi Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors
    Curtis E Margo
    University of South Florida College of Medicine, Tampa, Florida 33612, USA
    Am J Ophthalmol 143:538-9. 2007
  2. ncbi Rhinocerebral mucormycosis with perineural spread
    Curtis E Margo
    Department of Ophthalmology, James A Haley Veterans Hospital, Tampa, Florida, USA
    Ophthal Plast Reconstr Surg 23:326-7. 2007
  3. ncbi Post-marketing surveillance of ischaemic optic neuropathy in male veterans co-prescribed phosphodiesterase-5 inhibitors with organic nitrates or alpha-blockers
    Dustin D French
    VISN 8 Patient Safety Center of Inquiry, James A Haley VA Hospital, Tampa, Florida, USA
    Drug Saf 31:241-7. 2008
  4. ncbi Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort
    Dustin D French
    VISN 8 Patient Safety Center of Inquiry, James A Haley Hospital, Tampa, FL 33613, USA
    Retina 28:889-93. 2008
  5. ncbi Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration
    Dustin D French
    VISN 8 Patient Safety Center of Inquiry, Tampa, FL 33613, USA
    Cornea 26:1087-9. 2007
  6. ncbi Ocular pseudoexfoliation and cardiovascular disease: a national cross-section comparison study
    Dustin D French
    Department of Ophthalmology, Northwestern University Feinberg School of Medicine and VA Center of Excellence Chicago, IL, USA
    N Am J Med Sci 4:468-73. 2012
  7. ncbi Hospitalization for nontraumatic disorders of the eye and ocular adnexa: analysis of the Florida agency for health care administration data set
    Zuber D Mulla
    Discipline of Epidemiology, School of Public Health, El Paso Regional Campus, University of Texas Health Science Center at Houston, USA
    Arch Ophthalmol 122:262-6. 2004
  8. ncbi Prevalence of phosphodiesterase-5 inhibitor use in the VHA in 2004 and 2005 is twice that of a commercial health plan in 2001
    Dustin D French
    J Manag Care Pharm 12:692-3. 2006
  9. ncbi Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation
    Muna Ahmed
    Massachusetts Eye Research and Surgery Institute, Harvard Medical School, 8th Floor, 5 Cambridge Center, Cambridge, MA 02142, USA
    Int Ophthalmol 28:35-46. 2008

Collaborators

  • Dustin D French
  • Muna Ahmed
  • Zuber D Mulla
  • Robert Folberg
  • James G Caya
  • Yael Ben-Arie-Weintrob
  • Sofia Androudi
  • Michael B Raizman
  • Nicolette Gion
  • Ian W McLean
  • Morton E Smith
  • C Stephen Foster
  • John H Niffenegger
  • Frederick Albert Jakobiec

Detail Information

Publications9

  1. ncbi Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors
    Curtis E Margo
    University of South Florida College of Medicine, Tampa, Florida 33612, USA
    Am J Ophthalmol 143:538-9. 2007
    ..To determine the feasibility of a case-control study of phosphodiesterase (PDE)-5 inhibitors and nonarteritic ischemic optic neuropathy (NION)...
  2. ncbi Rhinocerebral mucormycosis with perineural spread
    Curtis E Margo
    Department of Ophthalmology, James A Haley Veterans Hospital, Tampa, Florida, USA
    Ophthal Plast Reconstr Surg 23:326-7. 2007
    ..Mucormycosis can spread considerable distances from its primary focus of infection along peripheral nerves, a phenomenon that can be identified clinically with contrast-enhanced MRI...
  3. ncbi Post-marketing surveillance of ischaemic optic neuropathy in male veterans co-prescribed phosphodiesterase-5 inhibitors with organic nitrates or alpha-blockers
    Dustin D French
    VISN 8 Patient Safety Center of Inquiry, James A Haley VA Hospital, Tampa, Florida, USA
    Drug Saf 31:241-7. 2008
    ..Because the interaction of phosphodiesterase-5 (PDE-5) inhibitors with either an organic nitrate or alpha-blocker may theoretically increase the risk of ION, we conducted a screening study to determine if such a risk might exist...
  4. ncbi Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort
    Dustin D French
    VISN 8 Patient Safety Center of Inquiry, James A Haley Hospital, Tampa, FL 33613, USA
    Retina 28:889-93. 2008
    ..Uveitis and scleritis are the most serious ocular side effects of bisphosphonate therapy. The purpose of this study was to determine the 6-month rates of uveitis/scleritis following dispensing of bisphosphonates in a large veteran cohort...
  5. ncbi Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration
    Dustin D French
    VISN 8 Patient Safety Center of Inquiry, Tampa, FL 33613, USA
    Cornea 26:1087-9. 2007
    ..To determine the proportion of patients who were dispensed amantadine and diagnosed with corneal edema or Fuchs dystrophy within specified time frames...
  6. ncbi Ocular pseudoexfoliation and cardiovascular disease: a national cross-section comparison study
    Dustin D French
    Department of Ophthalmology, Northwestern University Feinberg School of Medicine and VA Center of Excellence Chicago, IL, USA
    N Am J Med Sci 4:468-73. 2012
    ..The microfibrillar material that gives rise to the condition is visible clinically in the anterior segment of the eye, and is also found in other tissues, including blood vessels, skin, gallbladder, kidneys, lungs, and heart...
  7. ncbi Hospitalization for nontraumatic disorders of the eye and ocular adnexa: analysis of the Florida agency for health care administration data set
    Zuber D Mulla
    Discipline of Epidemiology, School of Public Health, El Paso Regional Campus, University of Texas Health Science Center at Houston, USA
    Arch Ophthalmol 122:262-6. 2004
    ..An opportunity exists to improve hospital efficiency and improve eye care by targeting the patients at highest risk for prolonged hospital stay...
  8. ncbi Prevalence of phosphodiesterase-5 inhibitor use in the VHA in 2004 and 2005 is twice that of a commercial health plan in 2001
    Dustin D French
    J Manag Care Pharm 12:692-3. 2006
  9. ncbi Diagnosis of limited ophthalmic Wegener granulomatosis: distinctive pathologic features with ANCA test confirmation
    Muna Ahmed
    Massachusetts Eye Research and Surgery Institute, Harvard Medical School, 8th Floor, 5 Cambridge Center, Cambridge, MA 02142, USA
    Int Ophthalmol 28:35-46. 2008
    ..To describe the clinical and histopathologic finding of very limited ophthalmic Wegener granulomatosis (WG)...